4//SEC Filing
Shields Matthew 4
Accession 0000950170-25-082498
CIK 0000818686other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 5:08 PM ET
Size
9.0 KB
Accession
0000950170-25-082498
Insider Transaction Report
Form 4
Shields Matthew
EVP, Global Operations
Transactions
- Sale
Ordinary Shares
2025-06-03$17.02/sh−6,206$105,628→ 9,989 total - Exercise/Conversion
Ordinary Shares
2025-06-03+16,195→ 16,195 total - Exercise/Conversion
Restricted Share Units
2025-06-03−16,195→ 48,587 total→ Ordinary Shares (16,195 underlying)
Footnotes (4)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II.
- [F4]Restricted share units were granted on June 3, 2024 with 16,195 vested on June 3, 2025, 16,195 vesting on each of June 3, 2026 and June 3, 2027, and 16,197 vesting on June 3, 2028.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0002025621
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 5:08 PM ET
- Size
- 9.0 KB